Managing Mild Traumatic Brain Injury Related Headaches With Repetitive Transcranial Magnetic Stimulation
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 179 people enrolled
- Started
- 1 Jan 2018
- Ended
- 31 Jan 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation
- Sham Transcranial Magnetic Stimulation
- Magnetic resonance imaging (MRI)
- Record updated
- 7 August 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- The following diagnostic criteria for MTBI based on the 1993 American Congress of Rehabilitation Medicine and recent recommendation from the DOD, and the current diagnostic criteria adopted by the VASDHS TBI Clinic will be used for the study. A traumatically induced physiological disruption of brain function, as manifested by at least one of the following:
- any loss of consciousness
- any loss of memory for events immediately before or after the accident
- any alteration in mental state at the time of the accident, e.g.:; feeling dazed; disoriented; confused)
- Focal neurologic deficit (s) that may or may not be transient but where the severity of the injury does not exceed the following:; loss of consciousness of approximately 30 min or less; after 30 min, an initial Glasgow Coma Scale score of 13-15; post-traumatic amnesia not greater than 24 hrs
- In addition, the following established diagnostic criteria for " Persistent headache attributed to mild traumatic injury headache" based on the International Classification of Headache Disorder (ICHD-3) will be applied to the study subjects:; A. Any headache fulfilling criteria C and D; B. Traumatic injury to the head has occurred; C. Headache is reported to have developed within 7 d after one of the following:; 1. injury to the head; 2. regaining of consciousness following the injury; 3. discontinuation of medication(s) that impairs the ability to sense or report headache following the injury; D. Headache persists for >3 mo after injury to the head; E. Not better accounted for by another ICHD-3 diagnosis; Additional Inclusion Criteria:
- no prior experience of TMS treatment
- average persistent headache intensity more than 30 on the 0-100 mechanical visual analog scale(M-VAS) at the screening visit (visit 1) and average persistent headache intensity score greater than 3/10 on a numerical rating scale (NRS) reported in the headache diary (between visits 1\&2)
- no history of daily persistent headache prior to the MTBI incidence
Who cannot take part
- any ferromagnetic material in the brain or body that would prohibit the patients from having a brain MRI, e.g.:; bullet fragment; shrapnel; device implant
- history of chronic headache diagnoses such migraine, tension or cluster headaches prior to the incidence of MTBI
- history of chronic headache prior to the MTBI incidence at a frequency more than once a month lasting more than one hour
- evidence in the chart of recent exacerbation of depressive or anxiety symptoms, active substance dependence, suicidal intent or attempt within the previous month, and/or current psychotic symptoms
- history of pacemaker implant
- history of dementia, major psychiatric or life threatening diseases
- history of seizure
- pregnancy; To be eligible for the study and to ensure no pregnancy risk, you will need to utilize contraception or practice abstinence until your study participation is completed
- presence of any other chronic neuropathic pain states
- pending litigation
- lack of ability to understand the experimental protocol and to adequately communicate in English
Where in United States
- VA San Diego Healthcare System, San Diego, CASan Diego, United States
About the trial
What the trial wants to find out
Persistent headache is one of the most common debilitating symptoms in military personnel suffering from mild traumatic brain injury (MTBI). This study aims to assess the long-term effect of repetitive transcranial magnetic stimulation (rTMS) in managing MTBI related headaches for up to 2-3 months by comparing the treatment effect of active-rTMS to sham-rTMS.
The 2 groups in the trial
- Transcranial Magnetic StimulationTreatment being tested
Active-repetitive transcranial magnetic stimulation (rTMS) at the left motor cortex.
Treatment: Transcranial Magnetic Stimulation and Magnetic resonance imaging (MRI)
- Sham Transcranial Magnetic StimulationSham treatment, for comparison
Sham rTMS will consist of the same parameters as active, however, the subject will not receive the actual magnetic stimulation to the left motor cortex.
Treatment: Sham Transcranial Magnetic Stimulation and Magnetic resonance imaging (MRI)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Long Term Efficacy of rTMS in Managing MTBI-related Headache
- Publications
- Long-term Efficacy of Repetitive Transcranial Magnetic Stimulation at Motor Cortex for Mild Traumatic Brain Injury-Related Headaches.Neuromodulation : journal of the International Neuromodulation Society, 2026
- Record updated
- 7 August 2025